Premier Biomedical Inc (BIEI)

[work-n-hard]

I think the main problem for most shareholders is that they thought when the first product rolled out in Jan., they would at least be showing some revenue by now, instead of declaring a loss with that joint venture that is now dissolved.
But, that's just my guess?

Page 6 of the latest Q :

CASH FLOWS FROM FINANCING ACTIVITIES 6 Months Ended June 30,2017

Proceeds from sale of stock, net of offering costs 435,000
Proceeds from sale of stock on equity line of credit 18,323
Proceeds from exercise of warrants, related party -
Proceeds from convertible notes payable -
Repayments of convertible notes payable -
Net cash provided by financing activities 453,323

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12244839